Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print

Industry News

Related Searches:

Filter by:

September 17, 2008
Pharmatek has opened its highly-potent and cytotoxic facility in San Diego, CA. The 18,000-sq.-ft. facility includes newly constructed analytical and formulation development labs and cGMP manufacturing suites for the development of highly-potent and…   Read More »
September 16, 2008
Charles River Labs has acquired Molecular Imaging Research, Inc. (MIR Preclinical Services) for approximately $12.5 million in cash. MIR, based in Ann Arbor, MI, provides discovery services using extensive in vivo imaging capabilities to pharmaceutic…   Read More »
September 16, 2008
Perrigo Co. has acquired JB Laboratories for approximately $44 million in cash. JB Labs is a contract manufacturer of OTC and nutrition products for healthcare suppliers in the U.S. The acquisition is expected to add more than $70 million in annual s…   Read More »
September 12, 2008
GlaxoSmithKline has formed GSK Oncology, a newly integrated Oncology R&D Organization. GSK Oncology unites small discovery units (DPUs) within the existing Centre of Excellence for Drug Discovery (CEDD), and a highly specialized drug development…   Read More »
September 12, 2008
TestPak has launched its latest child-resistant and senior-friendly compliance packaging system, Stora Enso’s Pharma DDS. Pharma DDS is a flexible and reclosable system with the capacity to contain a 30 count supply of most solid dose products…   Read More »
September 11, 2008
Quintiles Transnational Corp. will expand its Singapore operations to meet the growing demand in the Asia-Pacific region. The new regional headquarters will be double the size of its existing presence in Singapore. The company has also expanded seven…   Read More »
September 11, 2008
BioReliance Corp. has expanded its Rockville facilities and staff to accommodate the growing demand for its genetic toxicology testing services. BioReliance provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diag…   Read More »
September 11, 2008
Akorn, Inc. has entered into a 10-year exclusive contract manufacturing supply agreement with an undisclosed ophthalmic company. Under the terms of the agreement, Akorn will be responsible for the development, manufacturing and supply of two new opht…   Read More »
September 10, 2008
Azopharma Product Development Group announced the successful FDA audit of its Cyanta Analytical Laboratories facility in Maryland Heights, MO. The audit occurred from Aug 19-20 and produced no 483s or other major observations.    …   Read More »
September 10, 2008
Charles River Laboratories has completed the acquisition of privately held NewLab BioQuality AG, a Dusseldorf, Germany-based provider of safety and quality control services to biopharmaceutical clients. NewLab joins Charles River Biopharmaceutical Se…   Read More »
September 9, 2008
Bilcare Global Clinical Supplies has enhanced its global Phase III capabilities. The company has upgraded its Kalish large-scale bottling line at its U.S. facility and invested in new Pentapack blistering technology for expanded packaging capabilitie…   Read More »
September 9, 2008
West has completed expansion work at its Kinston, NC manufacturing facility. The expanded plant provides additional compounding and custom manufacturing capabilities and will bring more than 150 new jobs to Kinston and surrounding communities. The fa…   Read More »
September 8, 2008
The FDA has granted supplemental NDA approval for Akorn, Inc.'s IC-Green for Injection, USP. This approval is Akorn’s first lyophilized product approval for manufacture in its Decatur, IL production facility.     The company h…   Read More »
September 8, 2008
Bosch's Packaging Technology Division plans to acquire Paal Verpackungsmaschinen GmbH & Co. KG, based in Remshalden near Stuttgart. The purchase price was not disclosed.       Paal is a packaging and automation specialist t…   Read More »
September 8, 2008
The FDA has accepted data submitted from Bridge Laboratories' Beijing facility on behalf of a U.S. biotech client. The GLP nonhuman primate toxicology study data was generated and submitted as part of an IND package to the FDA. Bridge’s Beijing…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On